Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Ovarian Cancer
You must be logged in to create a new article
All Articles
Ann Conkle
Apr 13, 2012
DNA repair pathway information could predict chemotherapy response in ovarian cancer patients
Most advanced ovarian cancer patients undergo surgery to remove as much tumor as possible, and then undergo platinum-based chemotherapy. But... Read More
Fatima Rosario Omoso
Apr 5, 2012
DNA marker indicates if ovarian cancer treatment will be successful
Researchers of North Shore-LIJ Health System and the Feinstein Institute for Medical Research discovered that microRNA, a genetic marker embedded... Read More
Fatima Rosario Omoso
Apr 5, 2012
DNA marker indicates in ovarian cancer treatment will be successful
Researchers of North Shore-LIJ Health System and the Feinstein Institute for Medical Research discovered that microRNA, a genetic marker embedded... Read More
Ann Conkle
Feb 14, 2012
Newly discovered subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs
Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that... Read More
Elisabeth Manville
Feb 10, 2012
Researchers discover that most deadly form of ovarian cancer does not start in the ovaries
Scientists at McGill University have discovered that the most deadly form of ovarian cancer does not, in fact, originate in... Read More
Casey Kristin Frye
Dec 28, 2011
Targeted therapy treats advanced ovarian cancer
A Phase 3 clinical study, sponsored by the National Cancer Institute and conducted by the Gynecologic Oncology Group, demonstrated that... Read More